J. Mater. Sci. Technol. ›› 2022, Vol. 127: 245-255.DOI: 10.1016/j.jmst.2022.04.015

• Research Article • Previous Articles     Next Articles

Injectable self-healing polysaccharide hydrogel loading CuS and pH-responsive DOX@ZIF-8 nanoparticles for synergistic photothermal-photodynamic-chemo therapy of cancer

Zhiyi Qiana, Nuoya Zhaoa, Chunyao Wangb, Weizhong Yuana,*()   

  1. aSchool of Materials Science and Engineering, Key Laboratory of Advanced Civil Materials of Ministry of Education, Tongji University, Shanghai 201804, China
    bBeijing Research Institute of Chemical Industry (BRICI), Sinopec, Beijing 100013, China
  • Received:2022-02-07 Revised:2022-03-29 Accepted:2022-04-06 Published:2022-11-10 Online:2022-11-10
  • Contact: Weizhong Yuan
  • About author:* E-mail address: yuanwz@tongji.edu.cn (W. Yuan)

Abstract:

The injectable self-healing polysaccharide hydrogel was prepared by the formation of Schiff base bonds between aldehyde-modified methylcellulose (MC—CHO) and carboxymethyl chitosan (CMC). The copper sulfide nanoparticles (CuS NPs) and pH-sensitive doxorubicin-loaded zeolitic imidazolate frameworks nanoparticles (DOX@ZIF-8 NPs) were prepared and could be well-dispersed into the hydrogel system. The presence of CuS NPs can achieve photothermal therapy (PTT) for tumors under the irradiation of the near-infrared (NIR) laser. Moreover, CuS NPs can generate photodynamic effects under NIR irradiation, converting oxygen into toxic reactive oxygen species (ROS) and presenting efficient photodynamic therapy (PDT). The DOX@ZIF-8 NPs can be decomposed under an intracellular acidic environment and realize the controlled release of DOX. The injectable self-healing hydrogel loading CuS and DOX@ZIF-8 NPs can achieve synergistic photothermal-photodynamic-chemo therapy for tumors and will inspire the researchers to construct a platform from hydrogel combined with multifunctional nanomaterials to realize the effective multimodal therapy for tumor.

Key words: Injectable self-healing hydrogel, Copper sulfide, Zeolitic imidazolate frameworks, Synergistic cancer therapy